Rating Change
Truist Securities reiterated its Buy rating on Eli Lilly and Company (NYSE:LLY) on August 07, 2026.
reiterateNYSE:LLY
Truist Securities Reiterates Buy Rating on Eli Lilly and Company (LLY)
Truist Securities reiterated its Buy rating on Eli Lilly and Company (NYSE:LLY) on August 07, 2026.
At publication ·
What changed
Eli Lilly and Company (NYSE:LLY) · reiterate
- Firm
- Truist Securities
- Rating
- Buy to Buy
- Price at event
- $1,185.71
- Market capitalization
- $906.5B
At a glance
Key takeaways
- Truist Securities reiterated a Buy rating on Eli Lilly (LLY) on August 7, 2026, with the stock trading at $1,185.71 and a market capitalization of $906.5 billion.
Market Context
Eli Lilly and Company operates in the Healthcare sector. The stock currently trades at $1185.71 with a market capitalization of $906.5B. The stock has gained 11.9% over the past 52 weeks.
Analyst coverage from Truist Securities provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Eli Lilly and Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Eli Lilly and Company
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 07, 2026 | Truist Securities | Buy | N/A |
| Aug 06, 2026 | Wells Fargo | Overweight | N/A |
| Aug 06, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Jul 15, 2026 | Citigroup | Buy | N/A |
| Jul 14, 2026 | Bernstein | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View LLY Stock Page
Frequently Asked Questions
What does the Buy rating mean for LLY?
A rating of Buy from Truist Securities reflects the analyst's outlook on Eli Lilly and Company (NYSE:LLY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LLY forecast page.
